EASL Recommendations on Treatment of Hepatitis C 2015
Open Access
- 1 July 2015
- journal article
- guideline
- Published by Elsevier BV in Journal of Hepatology
- Vol. 63 (1), 199-236
- https://doi.org/10.1016/j.jhep.2015.03.025
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studiesVirology, 2013
- Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevirHepatology, 2013
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionHepatology, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Evaluation of Medication Adherence and Quality of Life in Patients With Hepatitis C Virus Receiving Combination TherapyGastroenterology Nursing, 2010
- Hepatitis C Virus and AlcoholSeminars in Liver Disease, 2009
- Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and PlaceAmerican Journal of Epidemiology, 2008
- A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virusDrug and Alcohol Dependence, 2008